Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. (Q36018942)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. |
scientific article |
Statements
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance (English)
A H Diacon
P R Donald
M Grobusch
R F Patientia
R Mahanyele
N Bantubani
R Narasimooloo
T De Marez
R van Heeswijk
N Lounis
P Meyvisch
K Andries
D F McNeeley
5 March 2012